CryoLife Reports First Quarter 2021 Financial Results

Go back to CryoLife Reports First Quarter 2021 Financial Results

CryoLife (CRY) PT Raised to $35 at Oppenheimer

April 30, 2021 6:10 AM EDT

Oppenheimer analyst Suraj Kalia raised the price target on CryoLife (NYSE: CRY) to $35.00 (from $29.00) while maintaining a Outperform rating.

The analyst commented, "CryoLife's 1Q21 revenues of $71.1M handily beat our/consensus estimates of $61.7M/$63.0M, up 7% y/y, bucking mid-February guide of... More

CryoLife (CRY) Tops Q1 EPS by 12c

April 29, 2021 4:46 PM EDT

CryoLife (NYSE: CRY) reported Q1 EPS of $0.03, $0.12 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $71.1 million versus the consensus estimate of $62.98 million.

"Despite the ongoing impact of COVID-19 on our business, we saw our business return... More